首页> 外文期刊>Current opinion in lipidology >Involvement of chemokine receptor 2 and its ligand, monocyte chemoattractant protein-1, in the development of atherosclerosis: lessons from knockout mice.
【24h】

Involvement of chemokine receptor 2 and its ligand, monocyte chemoattractant protein-1, in the development of atherosclerosis: lessons from knockout mice.

机译:趋化因子受体2及其配体,单核细胞趋化蛋白-1在动脉粥样硬化的发展中的参与:敲除小鼠的经验教训。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Blood monocytes are the precursors of the lipid-laden foam cells that are the hallmark of early atherosclerotic lesions, but the signals that initiate their recruitment to the vessel wall are poorly understood. Here, we review in vivo studies in genetically altered mice that support the notion that monocyte chemoattractant protein-1 (a member of the chemokine family of chemotactic cytokines) and chemokine receptor 2 (its cognate receptor) play important roles in this recruitment. An unexpected finding in chemokine receptor 2-knockout mice was the diminished production of interferon-gamma, which is a potent macrophage activator. The basis of this cytokine defect is not yet clear, but suggests that chemokines may influence atherosclerotic lesion development at several levels. Understanding the roles of chemokines and cytokines in atherogenesis may provide a basis for the development of future therapeutic agents that are aimed at interrupting monocyte recruitment and activation.
机译:血液单核细胞是充满脂质的泡沫细胞的前体,后者是早期动脉粥样硬化病变的标志,但启动它们募集到血管壁的信号知之甚少。在这里,我们回顾了对基因改造小鼠的体内研究,这些小鼠支持单核细胞趋化蛋白-1(趋化性细胞因子趋化因子家族的成员)和趋化因子受体2(其同源受体)在这一募集中起重要作用的观点。在趋化因子受体2基因敲除小鼠中的意外发现是干扰素-γ的产生减少,这是一种有效的巨噬细胞激活剂。这种细胞因子缺陷的基础尚不清楚,但表明趋化因子可能在多个水平上影响动脉粥样硬化病变的发展。了解趋化因子和细胞因子在动脉粥样硬化中的作用,可能为未来旨在中断单核细胞募集和激活的治疗剂的开发提供基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号